br

Brown & Brown

BRO
NYSE
$80.47
84
Good

Asset‑light cash compounding from a mission‑critical tollbooth

Brown & Brown is a scaled, acquisitive insurance distributor with very high cash conversion, low capital intensity, and sticky customer relationships.

The business earns the bulk of its revenue from commissions and fees for placing and servicing insurance, which renew annually and behave like a toll on risk transfer. 2024 delivered double‑digit organic growth and record profitability, and 2025 year‑to‑date includes the closing of Accession Risk Management Group, a transformational deal that materially increases scale across retail, wholesale and programs while temporarily depressing reported margins due to integration costs.

On trailing twelve months, we estimate free cash flow around 1.30 billion by combining nine‑month 2025 cash from operations and capex with Q4 2024 figures, consistent with Brown & Brown’s strong cash conversion history.

With approximately 341.4 million shares outstanding as of October 24, 2025, TTM FCF per share is roughly 3.80. The company authorized up to 1.5 billion for repurchases in October 2025 and increased its regular dividend for the 32nd consecutive year, signaling continued confidence and providing a path to offset 2025’s acquisition‑related share issuance.

Leverage rose with the Accession deal, but coverage remains supported by durable cash generation.

published on November 16, 2025 (54 days ago)

Does Brown & Brown have a strong competitive moat?

82
Good

Brown & Brown benefits from multiple, mutually reinforcing advantages. Switching costs are meaningful: mid‑market and specialty clients embed the broker into annual renewal, risk engineering, claims advocacy, regulatory navigation, and program design.

Those human and data relationships are not trivial to replicate, particularly in complex commercial lines. Scale and efficient distribution increase access to markets, speed to quote, and negotiating leverage with carriers, while programs (MGU) provide niche underwriting expertise and fee economics less dependent on the market cycle.

Brand and trust matter in insurance placement and claims resolution, where reputational capital and carrier relationships accumulated over decades are hard to copy. There is a mild marketplace effect between clients and carriers but it is not a pure network effect.

Risks to the moat include digital disintermediation in simple personal and very small commercial lines, and carrier consolidation. Brown & Brown’s breadth across retail, wholesale, and programs, global footprint of 700+ locations and 23,000+ teammates, and consistent organic growth indicate a durable, if not impregnable, moat.

Does Brown & Brown have pricing power in its industry?

70
Good

Pricing power is indirect because revenue is primarily commissions and fees tied to premium rates and exposures.

Brown & Brown cannot simply “name a price,” yet it captures value through mix shift to specialty lines and programs with higher margins, service fees, and contractual annual escalators. 2024 organic growth was 10.4%, aided by firm to moderately firm pricing in many lines; Q3‑25 organic growth of 3.5% reflects integration and some normalizing rate momentum.

Over long cycles, brokers have demonstrated the ability to hold or expand take‑rates with increasing complexity and service depth. Latent pricing power also exists in the ability to bundle risk services and analytics into programs. Constraints include competitive pressure in standard lines and rate softening in some markets.

How predictable is Brown & Brown's business?

88
Good

The business model is highly recurring with policy renewals creating a steady baseline.

Multi‑cycle performance shows consistent growth in commissions and fees, limited working capital demands, and low capex. 2024 delivered 12.9% total revenue growth and 10.4% organic, with EBITDAC‑adjusted margin expansion, while 2025 YTD maintained positive organic growth despite integration costs for Accession.

The company’s diversified segment mix (Retail, Programs, Wholesale Brokerage, Services) and geographic breadth dampen volatility. Exposure to macro shocks is mitigated by insurance’s non‑discretionary nature for most customers.

Key unpredictability drivers are rate‑cycle turns, weather‑related impacts on contingent commissions, and integration timing on large acquisitions, but these typically affect magnitude rather than direction of growth.

Is Brown & Brown financially strong?

76
Good

Brown & Brown’s balance sheet shifted in 2025 to fund the Accession acquisition with new senior notes and a follow‑on equity offering. As of Q3‑25, long‑term debt stood near 7.65 billion (plus 75 million current), and interest expense increased accordingly; however, trailing operating cash flow exceeds 1.3 billion and capex needs are minimal.

On our estimates, net debt to TTM FCF is roughly mid‑to‑high 5s, with a clear path to delever through organic cash generation while funding moderate buybacks and dividends. The board also authorized up to 1.5 billion in repurchases, providing flexibility to counter 2025 issuance over time.

Primary risks are a faster‑than‑expected softening of premium rates and slower synergy capture from Accession.

How effective is Brown & Brown's capital allocation strategy?

83
Good

Brown & Brown’s long record of high‑ROIC tuck‑ins continued with a step‑change acquisition in 2025: Accession. Management pre‑funded the deal with debt and equity to minimize closing risk, accepted near‑term integration costs, and outlined synergy levers across retail, wholesale, and programs.

The firm couples reinvestment with a conservative but rising dividend (32 consecutive annual increases) and, as of October 2025, a 1.5 billion repurchase authorization. Historically, capex has been de minimis and internal investments focus on talent, systems, and analytics.

Watchpoints: disciplined pricing for large M&A, integration execution, and avoiding permanent dilution. Early signals, including measured buyback authorization post‑deal and robust cash conversion, are favorable.

Does Brown & Brown have high-quality management?

90
Excellent

Founder‑influenced, owner‑oriented stewardship is a core strength. Chairman J. Hyatt Brown and CEO J. Powell Brown have cultivated a decentralized, performance‑driven culture that has compounded value for decades.

Management’s communication is conservative, with clear disclosures on organic growth, integration costs, and cash conversion, and a track record of integrating numerous acquisitions across cycles. The team has deep industry credibility and recently broadened leadership with seasoned operators in key segments.

Risks include key‑person dependence and the need to maintain culture as scale expands, but the organization’s bench and incentives appear aligned with long‑term compounding.

Good

Is Brown & Brown a quality company?

Brown & Brown is a good quality company with a quality score of 84/100

84
Good
  • High‑quality, recurring, asset‑light revenue with strong cash conversion; TTM FCF ≈ 1.30 billion and ≈ 3.80 per share on ~341 million diluted shares.
  • Scale step‑up: Accession (Risk Strategies and One80 Intermediaries) closed August 1, 2025, adding >5,000 teammates and expanding specialty distribution; near‑term integration costs offset by medium‑term synergy potential.
  • Organic momentum remains positive through cycles: 2024 organic revenue growth 10.4% and Q3‑25 organic growth 3.5% amid integration and cycling a strong prior year.
  • Capital allocation disciplined: 32nd straight annual dividend increase and a new authorization to repurchase up to 1.5 billion of stock, with room to delever on robust cash flows.
  • Key risks: rate‑cycle normalization, integration execution on Accession, higher leverage post‑deal, and potential digital disintermediation in simpler lines; mitigated by scale, cross‑sell breadth, and longstanding carrier and client relationships.

What is the fair value of Brown & Brown stock?

Is Brown & Brown a good investment at $80?

$80.47
Important Disclaimer:

The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.

Other stocks from New York Stock Exchange